4th Quarter - Report

BROWN RUDNICK LLP for LUPIN PHARMACEUTICALS, INC

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.2212 & S.974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

LobbyistCovered position, as disclosed
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2212 (115th), S. 974 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.